Biography of Mace Rothenberg
Last update: February 10, 2024Career
Mace Rothenberg joined Tango Therapeutics in 2008. Mace served as Chief Development Officer, Oncology and Chief Medical Officer for Tango Therapeutics.
Mace Rothenberg is currently- Director at Aulos Bioscience - View - Aulos Bioscience org chart
- Director at Tango Therapeutics - View - Tango Therapeutics org chart
- Independent Board Member at Surrozen - View - Surrozen org chart
Create your alert
to follow the career of Mace Rothenberg.
Education
Mace Rothenberg has a Residency Degree in Internal Medicine from Vanderbilt University in 1985 and a Fellowship in Medical Oncology from National Cancer Institute in 1988.
They have also studied at Vanderbilt University :
Find more alumni from Vanderbilt University
More about Mace Rothenberg
Selected links
Do you need to know more about Mace Rothenberg? More results.
Participate
Social media
- Mace Rothenberg on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Mace Rothenberg
The colleagues of Mace Rothenberg
Company Colleagues
- At Aulos Bioscience, Mace Rothenberg has 11 colleagues including Aron Knickerbocker (CEO), Michael Ehlers (Chairman of the Board)…
- At Tango Therapeutics, Mace Rothenberg has 22 colleagues including Barbara Weber (CEO & Director), Malte Peters (Director)…
- At Surrozen, Mace Rothenberg has 10 colleagues including Craig Parker (CEO & Director), Shao-Lee Lin (Director)…
Industry Colleagues
- In the Biotechnology industry, Mace Rothenberg has 30,401 colleagues in 2,291 companies located in 40 countries. 14,440 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mace Rothenberg.
Get in Touch
and ask for Mace Rothenberg.
